KR20020076375A - Cosmetics Useful for atopic skin - Google Patents

Cosmetics Useful for atopic skin Download PDF

Info

Publication number
KR20020076375A
KR20020076375A KR1020010016162A KR20010016162A KR20020076375A KR 20020076375 A KR20020076375 A KR 20020076375A KR 1020010016162 A KR1020010016162 A KR 1020010016162A KR 20010016162 A KR20010016162 A KR 20010016162A KR 20020076375 A KR20020076375 A KR 20020076375A
Authority
KR
South Korea
Prior art keywords
green tea
skin
extracts
aloe vera
ceramide
Prior art date
Application number
KR1020010016162A
Other languages
Korean (ko)
Inventor
한용구
이홍석
Original Assignee
(주)바이오랩
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)바이오랩 filed Critical (주)바이오랩
Priority to KR1020010016162A priority Critical patent/KR20020076375A/en
Publication of KR20020076375A publication Critical patent/KR20020076375A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE: A cosmetic containing ceramide, aloe vera, green tea extracts, Scutellaria baicalensis George extracts as an effective ingredient is provided which is effective for improvement of dermatoxerasia, pruritus and erythema of atopic skin. CONSTITUTION: The cosmetic contains one or more natural products selected from the group consisting of ceramide, aloe vera, green tea extracts and Scutellaria baicalensis George extracts, wherein the green tea extracts and Scutellaria baicalensis George extracts exhibit antibacterial activity against skin bacteria, the aloe vera, green tea extracts and Scutellaria baicalensis George extracts inhibit prostaglandin formation, and the ceramide has a moisturizing effect.

Description

아토피성 피부에 유용한 화장품{Cosmetics Useful for atopic skin}Cosmetics useful for atopic skin {Cosmetics Useful for atopic skin}

본 발명은 아토피성 피부에 유효한 천연물 및 그를 유효 성분으로 하는 화장품에 관한 것이다. 좀 더 구체적으로, 본 발명은 세라마이드, 알로에 베라, 녹차 추출물, 황금 추출물을 유효 성분으로 포함하며, 아토피성 피부의 건조감을 개선하고 피부 상제균의 정상화에 효과가 있는 화장품에 관한 것이다.The present invention relates to natural products effective for atopic skin and cosmetics containing the active ingredients thereof. More specifically, the present invention comprises a ceramide, aloe vera, green tea extract, golden extract as an active ingredient, and relates to a cosmetic that improves the dryness of atopic skin and is effective in normalizing skin fungus.

아토피성 피부라 함은 심한 가려움증, 만성 피부발진이 특징인 질환으로 흔히 태열이라고도 부르며 유아 습진의 가장 흔한 형태이다. 그의 원인은 아직까지 명확히 밝혀지지 않았지만 아토피 피부염 환자의 약 70%에서 아토피의 병력이 있었으며 알레르기성 체질인 사람에서 호발하고 특히 알러지성 비염, 천식 등을 동반하여 유전적 요인이나 면역 질환의 하나로 이해하고 있다. 이 병의 특징으로 초기의 심한 가려움증에 의해 대부분이 피부를 긁고 이에 따른 2차 감염과 특히 환자의 정신적 안정 및 감정의 상태에 따라 더욱 악화될 수도 있다.Atopic dermatitis is a disease characterized by severe itching and chronic skin rash. It is often called febrile fever and is the most common form of infant eczema. Although its cause is not yet clear, about 70% of patients with atopic dermatitis had a history of atopic dermatitis, and it is called in allergic congenitals, especially with allergic rhinitis and asthma. have. The disease is characterized by the initial severe itching, which is most likely to be aggravated by scratching the skin and subsequent secondary infections, especially the patient's mental stability and emotional state.

아토피성 피부염 치료 영역에서는 여러 가지 약재들이 개발되어 사용되고 있지만 적절한 피부 관리를 위한 화장품의 선택은 고보습 제품만이 있을 뿐 아직까지미흡한 부분이 많은 실정이다.In the field of atopic dermatitis treatment, various medicines have been developed and used, but the selection of cosmetics for proper skin care is only a highly moisturizing product, but there are still many areas that are insufficient.

아토피성 피부염에는 스테로이드나 항히스타민 제제, 부신피질호르몬 제제, 2차 감염이 됐을 때 항생제 등을 사용하지만 이는 주로 의약품 영역의 원료들이며 화장품 영역에서는 주로 오일류나 고보습인자 등 보습 효과가 뛰어나 유효 물질을 사용하여 주로 질환의 치료보다는 아토피성 피부의 건조감을 완화하는 개념이다. 또한 피부 각질세포간 지질중 하나인 세라마이드(ceramide)가 아토피성 피부에서는 정상 피부에 비해 감소된다는 최근 연구 보고에 따라 세라마이드를 통한 피부 장벽 기능 개선 화장품도 있다. 그러나 이러한 원료들은 기존의 보습 효과에만 의존한 것으로 가려움증 등 아토피성 피부의 주된 증상을 개선하는데 그 효과가 미미한 실정이다.For atopic dermatitis, steroids, antihistamines, corticosteroids, and antibiotics are used in secondary infections, but they are mainly used in pharmaceuticals, and in cosmetics, effective substances are used because they have excellent moisturizing effects such as oils and high moisturizing factors. This is mainly a concept to relieve dryness of atopic skin rather than the treatment of diseases. In addition, according to a recent research report that ceramide (ceramide), which is one of skin keratinocyte lipids, is reduced in atopic skin compared to normal skin, there is a cosmetic product for improving skin barrier function through ceramide. However, these raw materials rely only on existing moisturizing effects, and the effects of improving the main symptoms of atopic skin such as itching are insignificant.

즉, 지금까지의 화장품은 주로 앞서 기술한 아토피성 피부의 여러 증상 중 건조감 완화를 주목적으로 개발되어 그 치유 효과도 미미한 상황이며 Staphylococcus aureus에 대한 항균력이 있는 화장품 원료 개발은 부족한 상황이다.That is, until now, cosmetics have been mainly developed to alleviate dryness among the various symptoms of atopic skin described above, and its healing effect is insignificant, and development of cosmetic raw materials with antibacterial activity against Staphylococcus aureus is insufficient.

따라서 본 발명자들은 아토피성 피부의 건조감 완화는 물론 항염증 작용을 통한 홍반 억제, 피부 상제균에 대한 항균 물질을 함유한 화장품을 개발하기 위하여 예의 연구를 거듭한 결과, 세라마이드의 건조감 완화 효과와 알로에 베라, 녹차 추출물, 황금 추출물의 항염증 효과, 녹차 추출물의 항균 효과를 통해 아토피성 피부를 개선하는데 효과가 있다는 것을 발견하여 본 발명을 완성하게 되었다.Therefore, the present inventors have intensively studied to reduce the dryness of atopic skin, as well as to suppress erythema through anti-inflammatory action, and to develop cosmetics containing antibacterial substances against skin fungus. As a result, ceramide reduces the dryness and aloe vera. The green tea extract, the anti-inflammatory effect of the golden extract, through the antimicrobial effect of the green tea extract was found to be effective in improving atopic skin, thereby completing the present invention.

즉, 본 발명의 목적은 세라마이드와 알로에 베라, 녹차 추출물, 황금 추출물이 함유된 아토피성 피부에 유효한 화장품을 제공함에 있다.That is, an object of the present invention is to provide an effective cosmetic for atopic skin containing ceramide, aloe vera, green tea extract, and golden extract.

상기 목적을 달성하기 위한 본 발명에 따른 아토피성 피부에 유효한 화장품은 천연물 중 황금, 녹차, 알로에 베라와 세라마이드로 이루어진 군에서 선택된 적어도 하나 이상을 함유하는 것을 특징으로 한다.Cosmetics effective for atopic skin according to the present invention for achieving the above object is characterized in that it contains at least one selected from the group consisting of gold, green tea, aloe vera and ceramide of natural products.

본 발명에 따른 화장품은 조성분 중 피부 보습을 효과적으로 유지할 수 있도록 처방되어 있다. 또한 항염증 물질인 알로에 베라, 녹차 추출물, 황금 추출물, 항균 물질인 녹차 추출물 등을 혼합하여 아토피에 유효한 원료 조성으로 이루어져 있다.Cosmetics according to the present invention is prescribed to effectively maintain the skin moisture in the composition. In addition, aloe vera, green tea extract, golden extract, antimicrobial green tea extract, etc., which is an anti-inflammatory substance, is mixed to form an effective ingredient composition for atopy.

본 발명에 따른 아토피용 화장품에 사용되는 천연물은 다음과 같다.Natural products used in the cosmetic for atopy according to the present invention are as follows.

1) 알로에 베라1) Aloe Vera

학명: Aloe veraScientific name: Aloe vera

식물: 다년생 초본으로 줄기는 매우 짧다. 잎은 줄기 끝에 모여 나고 즙이 많다. 액즙은 노회라고 불리며 한약재로 사용된다.Plant: A perennial herb, stems are very short. The leaves gather at the end of the stem and are succulent. The juice is called presbyopia and is used as a herbal medicine.

성분: 액즙에는 알로인, 쿠마릭산, 단백질 및 많은 칼슘이 함유되어 있다.Ingredients: The juice contains alloin, coumalic acid, protein and a lot of calcium.

작용: 알로에의 액즙은 피부의 창상 및 열상 치료에 효과적이다. 또한 항암 활성이 있는 것으로 밝혀졌다.Action: Aloe juice is effective for the treatment of wounds and lacerations of the skin. It has also been found to have anticancer activity.

응용: 동의 치료에서 알러지성 비염, 태열 등에 사용한다.Application: Used in allergic rhinitis, fever, etc. in the treatment of sinus.

2) 황금2) golden

학명 : Scutellaria baicalensis GeorgiScientific name: Scutellaria baicalensis Georgi

식물 : 다년생 초목으로 높이 25 - 60cm이며 줄기는 네모지고 밑부분에 많은 가지가 있음. 뿌리 부분이 한약재로 사용되는 황금임.Plants: perennial vegetation, 25-60cm high, stems squared, many branches at bottom. The root part is golden used as a herbal medicine.

성분 : 바이칼레인(baicalein), 바이칼린(baicalin), 우고닌(wogonoside) 등을 함유한다.Ingredients: Contains baicalein, baicalin, wogonoside.

작용 : 해열, 소염, 항알러지 등의 작용을 나타내며 혈압을 저해시키는 작용을 한다.Action: It is an antipyretic, anti-inflammatory, anti-allergic effect, and inhibits blood pressure.

응용 : 동의에 의하면 구토, 코 부위의 출혈 등에 사용한다.Application: According to agreement, it is used for vomiting and bleeding in the nose area.

3)녹차3) green tea

학명 : Camellia sinensisScientific name: Camellia sinensis

식물 : 다년생 초목으로 녹차는 차나무의 어리고 연한 잎이다. 보통 3년생 이후 잎을 채취할 수 있다.Plant: A perennial vegetation, green tea is the young and tender leaf of the tea tree. Usually leaves can be harvested after 3 years.

성분 : 1-5%의 카페인과 퓨린류의 알카로이드를 함유하고 있으며 탄닌과 플라보노이드 성분을 다량 함유하고 있다.Ingredients: Contains 1-5% of caffeine and purine alkaloids, and contains large amounts of tannins and flavonoids.

작용 : 항산화 및 항염 효과, 항균, 이뇨 작용, 항암 효과 등이 보고되고 있다.Action: Antioxidant and anti-inflammatory effects, antibacterial, diuretic and anticancer effects have been reported.

응용 : 동의에는 두통, 말라리아 등에 사용한다.Application: Used for headache, malaria, etc. in motion.

상기 원료 성분의 아토피성 피부에 대한 유효능을 알아보기 위하여 다음과같은 시험을 실시하였고 이하 실시예를 통하여 본 발명을 보다 상세히 설명하고자 한다. 이들 실시 예는 본 발명을 보다 구체적으로 설명하기 위한 것으로 본 발명의 요지에 따라 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다는 것은 당업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.In order to determine the effective ability of the raw material for atopic skin, the following test was carried out and the present invention will be described in more detail with reference to the following examples. These examples are intended to illustrate the present invention in more detail, and it will be apparent to those skilled in the art that the scope of the present invention is not limited by these examples according to the gist of the present invention.

[실시예 1: 추출물의 제조]Example 1: Preparation of Extract

잘 건조되어진 녹차, 황금을 분쇄하고, 에탄올 또는 열수를 이용하여 다음과 같이 추출하였다.The green tea and gold, which were well dried, were ground and extracted using ethanol or hot water as follows.

우선, 열수 추출물의 제조에 있어서, 건조된 황금 20 내지 80g에 증류수를 500ml을 넣고 실온에 24시간 방치한 다음, 30분 동안 끓여 여과지를 이용, 여과하고 8,000×g에서 15분간 원심분리하여 상층액만 취하였다. 이어, 전기 상층액을 회전식 진공증발기(rotatory vacuum evaporimeter)로 60℃ 수욕상에서 감압 농축하고, 냉동건조기(freeze dryer)로 동결건조하였다.First, in the preparation of hot water extract, 500 ml of distilled water was added to dried golden 20 to 80 g and left at room temperature for 24 hours, then boiled for 30 minutes, filtered using a filter paper, and centrifuged at 8,000 × g for 15 minutes. Only drunk. The supernatant was then concentrated under reduced pressure on a 60 ° C. water bath with a rotary vacuum evaporimeter and lyophilized with a freeze dryer.

에탄올 추출물은 다음과 같이 제조하였다. 즉, 건조된 녹차, 황금 시료 20g에 500ml의 80% 에탄올을 넣어 0℃ 항온기에서 18시간 동안 침적하고 추출액을 여과지에 여과한 다음, 8,000×g에서 15분간 원심분리하고 상층액을 회전식진공증발기로 감압농축한 후 동결건조하였다.Ethanol extract was prepared as follows. In other words, 500 g of 80% ethanol was added to 20 g of dried green tea and golden sample, which was immersed in a 0 ° C. thermostat for 18 hours, the extract was filtered through a filter paper, and centrifuged at 8,000 × g for 15 minutes, and the supernatant was rotated by a rotary vacuum evaporator. It was concentrated under reduced pressure and lyophilized.

[실시예 2 : Staphylococcus aureus에 대한 항균력 시험]Example 2 Antibacterial Activity Test against Staphylococcus aureus

1. 시험 방법 및 결과1. Test Methods and Results

Staphylococcus aureus에 대한 항균력 시험은 액체 배지 희석 방법으로 하였다. 액체 영양배지 2 ml에 각 시료를 0에서 1000ppm까지 100ppm 간격으로 희석한 후 106/ml의 균액 20 μl를 접종하여 24 시간 동안 배양시켰다. 혼탁도를 기준으로 성장이 저해된 최소농도를 최저 성장 저해 농도(MIC)라고 정의하였다.Antimicrobial activity test against Staphylococcus aureus was done by liquid media dilution method. After diluting each sample in 100 ml intervals from 0 to 1000 ppm in 2 ml of liquid nutrient medium, 20 μl of 106 / ml of the bacterial solution was inoculated and incubated for 24 hours. The minimum concentration at which growth was inhibited based on turbidity was defined as the minimum growth inhibition concentration (MIC).

그 결과는 표 1과 같다.The results are shown in Table 1.

Staphylococcus aureus에 대한 항균력 시험 결과Antimicrobial Activity Test Results for Staphylococcus aureus 시료sample 최저성장저해농도(ppm)Minimum growth inhibition (ppm) 녹차green tea 200-300200-300 황금Gold 400-500400-500

표 1에 나타낸 바와 같이, 황금, 녹차가 Staphylococcus aureus에 대한 항균력이 특히 우수함을 알 수 있다.As shown in Table 1, it can be seen that gold, green tea is particularly excellent antibacterial activity against Staphylococcus aureus.

[실시예 3 : 항염증 시험]Example 3: Anti-inflammatory Test

1. 시험 방법 및 결과1. Test Methods and Results

항염증 효과는 프로스타글란딘의 생성 억제 효과로 평가하였다. 전기 추출된 추출된 추출물을 이용 대식세포를 대상으로 효과를 측정하였다. 우선, 마우스의 복강에서 채취한 대식세포에 최종 농도가 500uM이 되도록 아스피린을 첨가해 세포에 잔존하는 COX(cyclooxygenase) 활성을 비가역적으로 억제하였다. 그런 다음, 전기 현탁액을 96웰의 세포 배양관(96 well plate)의 각 웰에 100ul를 하여 5% CO2와 37℃ 조건의 배양기에서 2시간 동안 배양하여 대식 세포를 용기 표면에 부착시켰다. 이어, 부착된 대식 세포를 PBS로 3회 세척한 후, 이를 추출물의 효과 시험에 사용하였다.The anti-inflammatory effect was evaluated by the inhibitory effect of the production of prostaglandins. The effects of macrophages were measured using the extracted extracts. First, aspirin was added to macrophages taken from the abdominal cavity of mice to a final concentration of 500 uM to irreversibly inhibit the COX (cyclooxygenase) activity remaining in the cells. The suspension was then incubated for 2 hours in an incubator at 37 ° C. with 5% CO 2 in 100 ul of each well of a 96 well cell culture tube (96 well plate) to attach macrophages to the vessel surface. The attached macrophages were then washed three times with PBS and then used for the effect test of the extract.

전기 배양된 대식세포 5×104 cell/ml에 LPS를 1%(w/v)로 함유하는 RPMI 배지를 첨가하여 12시간 동안 배양한 후, 프로스타글란딘의 생성을 유발하고 추출물을 100ul 처리하여 유리된 프로스타글란딘을 효소면역 분석법(ELISA)을 이용하여 정량하였다. 이때, 추출물의 프로스타글란딘의 생성억제 활성은 LPS를 처리한 군과 처리하지 않은 군에서 각각 생성된 프로스타글란딘의 차이를 100%로 설정하고 LPS와 시료를 함께 처리하여 감소된 프로스타글란딘의 백분율을 통하여 대조군과 비교, 판정하였으며 그 결과를 다음 표 2에 나타내었다.After incubation for 12 hours by adding RPMI medium containing 1% (w / v) of LPS to 5 × 104 cells / ml of electrocultured macrophages, prostaglandins were produced and 100ul of the extract was treated to release prostaglandins. Was quantified using an enzyme immunoassay (ELISA). At this time, the production inhibitory activity of the prostaglandin of the extract was set to 100% the difference between the prostaglandin produced in the LPS treated group and the untreated group and compared with the control group through the percentage of prostaglandin reduced by treating the LPS and the sample together. , And the results are shown in Table 2 below.

프로스타글란딘의 생성억제효과Inhibitory Effect of Prostaglandins BlankBlank 대조군(아스피린 처리군)Control group (Aspirin treated group) 녹차 0.01%Green Tea 0.01% 황금 0.01%0.01% golden 알로에 0.01%Aloe 0.01% 100.0%100.0% 23.4%23.4% 34.6%34.6% 42.2%42.2% 31.8%31.8%

[실시예 4: 인체피부 일차 자극시험]Example 4 Primary Skin Stimulation Test

상기 시험예 1-3의 결과로부터 알로에 베라, 황금, 녹차가 아토피성 염증에 의한 홍반 반응 및 피부 상제균에 대한 항균력이 있음을 알 수 있으며, 상기 천연물들이 화장품에 적용하였을 경우 인체에 유해한지의 여부를 알아보기 위하여 인체피부자극시험을 하였다.From the results of Test Example 1-3, it can be seen that aloe vera, gold, and green tea have antimicrobial activity against erythema reaction and skin fungus caused by atopic inflammation, and whether the natural products are harmful to human body when applied to cosmetics. Human skin stimulation test was conducted to determine whether or not.

인체피부 일차 자극시험은 인체 첩포시험(human patch test)으로 하였다. 즉, 20-30세의 건강한 여성 30명을 대상으로 CTFA 가이드라인(The Cosmetic, Toiletry and Fragrance Association. Inc. Washington, D.C., 20036, 1991)에 따라 실시하였다. 핀 챔버(Finn Chamber)에 준비된 시험물질(10% in patch base) 20㎕를 적하시킨 후 70% 에탄올로 세척한 후 건조시키고, 시험부위인 등 부위에 얹어 미소공 테이프(micropore tape)로 고정시켰다. 첩포는 24시간 동안 도포하며, 첩포를 제거한 후는 마킹팬(marking pen)으로 시험부위를 표시하며 30분, 24시간 후에 각 시험 부위의 피부반응을 관찰하여 국제 접촉 피부염 연구회(International Contact Dermatitis Research Group; ICDRG)의 규정에 따라 판정하였다. 그 결과는 표 4와 같다.Human skin primary stimulation test was a human patch test (human patch test). That is, 30 healthy women aged 20-30 years old were tested according to CTFA guidelines (The Cosmetic, Toiletry and Fragrance Association. Inc. Washington, D.C., 20036, 1991). 20 μl of the test substance (10% in patch base) prepared in the Finn Chamber was added dropwise, washed with 70% ethanol, dried, and fixed on the back of the test site with a micropore tape. . The patch is applied for 24 hours, and after removing the patch, the marking area is marked with a marking pen. After 30 minutes and 24 hours, the skin reaction of each test site is observed and the International Contact Dermatitis Research Group ; ICDRG). The results are shown in Table 4.

표 4에서 평균반응도는 아래의 수학식 2에 따라 계산하였으며, ±는 1점, +는 2점, ++는 3점, +++는 4점으로 하였다. 판정기준은 등급Ⅰ(무자극범위)은 1미만, 등급Ⅱ(경자극범위)는 3미만, 등급Ⅲ(중자극범위)은 5미만, 등급Ⅳ(강자극범위)는 5이상을 기준으로 하였다.In Table 4, the average reactivity was calculated according to Equation 2 below, ± was 1 point, + was 2 points, ++ was 3 points, and +++ was 4 points. The criterion was based on less than 1 grade I (non-irritating range), less than 3 grade II (light stimulation range), less than 5 grade III (medium stimulation range), and 5 or more grade IV (strong stimulus range). .

시험물질Test substance 24시간24 hours 48시간48 hours 평균반응도(n=30)Average reactivity (n = 30) 판정등급Judgment grade ±± ++ ++++ ++++++ ±± ++ ++++ ++++++ 아토피 베이스(Atopy base)Atopy base 55 -- -- -- 1One -- -- -- 2.502.50 베이스+녹차0.4%Base + green tea 0.4% 66 -- -- -- 1One -- -- -- 2.922.92 베이스 + 황금 0.4%Base + Golden 0.4% 66 -- -- -- -- -- -- -- 2.752.75 베이스 + 알로에 베라 0.4%Base + Aloe Vera 0.4% 66 -- -- -- -- -- -- -- 2.752.75 베이스 + 황금0.2% + 녹차0.2% +알로에 베라 0.2%Base + Golden 0.2% + Green Tea 0.2% + Aloe Vera 0.2% 66 -- -- -- -- -- -- -- 2.752.75

표 3에서 나타낸 것처럼, 아토피 베이스는 안전 범위의 자극 수치를 나타내었으나 자극이 다소 높은 편이다. 모든 원료들이 시험처방에서 등급 Ⅱ 이상의 자극을 나타내었다. 여러 가지 원료를 조합한 처방의 경우 모두 안전범위인 등급 Ⅱ(자극수치 3미만) 수준이었다.As shown in Table 3, atopy bases exhibited a safe range of stimulus values, but tended to be somewhat higher. All raw materials showed grade II or higher stimulation at the test prescription. In the case of a combination of various ingredients, the level of safety was Grade II (less than 3 stimulus level).

[실시예 1-25][Example 1-25]

하기 표 4 및 5의 조성으로 천연물이 함유된 화장품을 제조후, 각각 제조된 화장품에 대하여 피부 수분량의 변화, 유효성 평가 및 부작용 평가를 하였으며, 그 결과는 표 6과 같다.After the preparation of the cosmetics containing natural products in the compositions of Tables 4 and 5, the changes in skin moisture content, efficacy evaluation and side effects were evaluated for the prepared cosmetics, respectively, and the results are shown in Table 6.

피부 수분량 변화의 평가 : 코네오미터(Corneometer)를 이용하여 시료 처치전과 처치 한달 후의 결과를 비교하여 증가된 비를 통하여 피부 수분량 변화를 평가하였다.Evaluation of Skin Moisture Change: The change of skin moisture content was evaluated through the increased ratio by comparing the results before and 1 month after treatment with a corneometer.

유효성 평가 : 시료 처치 전의 피검자의 설문 조사를 통해 가려움증과 홍반의 정도를 평가하고 처치 한달 후 다시 피검자의 설문 평가를 통해 가려움증과 홍반의 감소가 통계적으로 유효한 수준(3단계 이상 개선)인 피검자와 전체 피검자의 백분율을 통하여 시료의 유효성을 평가하였다. 예를 들면, 유효성 50%는 전체 피검자 중 가려움증이나 홍반이 3단계 이상 개선된 50%인 것을 의미한다.Efficacy evaluation: The patient's questionnaire was evaluated before the sample treatment, and the degree of itching and erythema was assessed. The validity of the sample was evaluated through the percentage of subjects. For example, an effective 50% means that the itch or erythema is 50% improved in at least three stages among all the subjects.

부작용 평가 : 피검자의 설문조사를 통한 자극 등 부작용의 유무와 평가자인 피부과 의사 2명이 직접 피검자의 피부 상태를 평가한 것을 종합하여 부작용 유무를 판정하였다.Side effects evaluation: The presence or absence of side effects such as irritation through the survey of the subjects, and the dermatologist, the evaluator, directly evaluated the skin condition of the subjects to determine the side effects.

조성Furtherance 함량(%)content(%) Stearic acidStearic acid 1.201.20 Eldew CL-301Eldew CL-301 0.600.60 Cetanol-kCetanol-k 2.002.00 GMS #105GMS # 105 1.201.20 Crodalan SWLCrodalan SWL 1.501.50 Wecobee SSWecobee SS 1.501.50 Arl #165Arl # 165 1.501.50 Myrj #52SMyrj # 52s 1.701.70 Arl #83Arl # 83 0.400.40 D-MD-M 0.200.20 D-PD-P 0.100.10 MDFMDF 4.004.00 ODOODO 5.005.00 CEHCEH 5.005.00 DC 200FDC 200F 0.500.50 Vitamin E acetateVitamin E acetate 0.500.50 Ceramide PC 104Ceramide PC 104 1.201.20 CholesterolCholesterol 0.500.50 Linoleic acidLinoleic acid 1.001.00 C6-PSC6-PS 0.300.30 KeramideKeramide 0.000.00 DC 345DC 345 5.005.00 FragranceFragrance 0.100.10 Dl-waterDl-water to 100to 100 EDTA-2NaEDTA-2Na 0.020.02 GlycerineGlycerin 6.006.00 1,3 BG1,3 BG 4.004.00 PGPG 3.003.00 Bio-HEBio-HE 5.005.00 SC-glucanSC-glucan 5.005.00 Flocare ET-58Flocare ET-58 0.600.60

하기 표 5에서 0 표시는 표 4의 조성에 0 표시된 천연물이 추가로 사용되었음을 나타낸다. 또한 각 실시예에서 사용된 천연물의 함량은 실시 1부터 7까지는 황금 0.2%, 녹차 0.2%, 알로에 베라 0.2%이고 8부터 14까지는 황금 0.3%, 녹차 0.5%, 알로에 베라 0.5%이다.0 in Table 5 indicates that a natural product labeled 0 is additionally used in the composition of Table 4. In addition, the amount of natural products used in each of Examples 1 to 7 is golden 0.2%, green tea 0.2%, aloe vera 0.2% and 8 to 14 is golden 0.3%, green tea 0.5%, aloe vera 0.5%.

천연물Natural products 실시예Example 1One 22 33 44 55 66 77 88 99 1010 1111 1212 1313 1414 황금Gold 녹차green tea 00 00 알로에Aloe 00 00

실시예Example 피부 수분량 변화Skin moisture change 유효성 평가Effectiveness evaluation 부작용 평가Side effects assessment 1One 10% 증가10% increase 35%35% 미약한 홍반, 가려움Weak erythema, itching 22 10% 증가10% increase 25%25% 미약한 홍반, 가려움Weak erythema, itching 33 10% 증가10% increase 43%43% 미약한 홍반, 가려움Weak erythema, itching 44 10% 증가10% increase 35%35% 미약한 홍반, 가려움Weak erythema, itching 55 10% 증가10% increase 20%20% 미약한 홍반, 가려움Weak erythema, itching 66 10% 증가10% increase 26%26% 미약한 가려움Weak itching 77 10% 증가10% increase 20%20% 미약한 홍반, 가려움Weak erythema, itching 88 10% 증가10% increase 46%46% 미약한 홍반, 가려움Weak erythema, itching 99 10% 증가10% increase 48%48% 미약한 홍반, 가려움Weak erythema, itching 1010 10% 증가10% increase 60%60% 미약한 홍반, 가려움Weak erythema, itching 1111 10% 증가10% increase 50%50% 미약한 홍반, 가려움Weak erythema, itching 1212 10% 증가10% increase 47%47% 미약한 홍반, 가려움Weak erythema, itching 1313 10% 증가10% increase 38%38% 미약한 홍반, 가려움Weak erythema, itching 1414 10% 증가10% increase 43%43% 미약한 홍반, 가려움Weak erythema, itching

상기 표 6에 나타낸 바와 같이, 실시예 10의 경우가 가장 이상적이었으며, 함유된 천연물의 농도가 높을수록 홍반과 가려움증의 개선 효과가 높은 것으로 나타났다.As shown in Table 6, the case of Example 10 was the most ideal, the higher the concentration of natural products contained was found to have a higher effect of improving the erythema and itching.

이상에서 설명하고 입증하였듯이, 본 발명은 녹차, 황금, 알로에 베라와 세라마이드 및 전기 추출물 또는 그들의 혼합물을 유효성분으로 포함하며 아토피성 피부의 건조증과 가려움증, 홍반을 개선하는 데 효과가 있는 화장품을 제공한다. 본 발명의 녹차와 황금은 피부 상제균에 대한 항균력을 나타내며, 알로에 베라와 녹차, 황금은 프로스타글란딘의 생성을 억제하며, 세라마이드는 보습 효과가 있다. 아울러 전기 추출물 또는 이들의 혼합물을 실제 피부에 도포하였을 경우에 안전성을 가짐을 확인하였는 바, 본 발명의 추출물 또는 추출물의 혼합물을 아토피성 피부의 건조증과 가려움증, 홍반의 개선을 위한 화장품의 유효 성분으로 유용하게 활용될 수 있을 것이다.As described and demonstrated above, the present invention includes a green tea, golden, aloe vera and ceramide and an electric extract or a mixture thereof as an active ingredient and provides a cosmetic that is effective in improving dryness, itching and erythema of atopic skin . Green tea and gold of the present invention exhibit antimicrobial activity against skin fungus, aloe vera and green tea, gold inhibits the production of prostaglandins, ceramide has a moisturizing effect. In addition, it was confirmed that the extract or the mixture of the present invention is safe when applied to the actual skin, the extract or the mixture of the present invention as an active ingredient of cosmetics for the improvement of dryness and itching, erythema of atopic skin It may be useful.

Claims (1)

천연물 중 황금, 녹차, 알로에 베라 및 세라마이드로 이루어진 군에서 선택된 적어도 하나 이상의 천연물을 함유하는 것을 특징으로 하는 아토피성 피부에 유효한 화장품.Cosmetics effective for atopic skin, comprising at least one natural product selected from the group consisting of gold, green tea, aloe vera and ceramide among natural products.
KR1020010016162A 2001-03-28 2001-03-28 Cosmetics Useful for atopic skin KR20020076375A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020010016162A KR20020076375A (en) 2001-03-28 2001-03-28 Cosmetics Useful for atopic skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020010016162A KR20020076375A (en) 2001-03-28 2001-03-28 Cosmetics Useful for atopic skin

Publications (1)

Publication Number Publication Date
KR20020076375A true KR20020076375A (en) 2002-10-11

Family

ID=27698972

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020010016162A KR20020076375A (en) 2001-03-28 2001-03-28 Cosmetics Useful for atopic skin

Country Status (1)

Country Link
KR (1) KR20020076375A (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040026268A (en) * 2002-09-23 2004-03-31 바이오스펙트럼 주식회사 Topical composition for lowering pruritus or damaged skin barrier caused by atopic dermatitis
KR100451444B1 (en) * 2001-10-19 2004-10-06 이석일 Cosmetic composition for treating atopic dermattis
KR100564153B1 (en) * 2002-11-28 2006-03-27 주식회사 에이치 엔 비티 A composition for improving the atopic dermatitis
KR100700912B1 (en) * 2005-12-30 2007-03-28 고려대학교 산학협력단 Human Cell Binding Inhibitory Activity of Acne Bacillus and Atopic Staphylococcus aureus Containing Acidic Polysaccharides Isolated from Green Tea Leaves
KR100723370B1 (en) * 2005-12-30 2007-05-30 대구한의대학교산학협력단 Cosmetic composition comprising the extract of scutellaria baicalensis and coptis chinensis showing hydrating effect and antibacterial effect
KR100797139B1 (en) * 2006-04-11 2008-01-24 허재원 Pack composition comprising Skullcap and Black Rice
KR100824958B1 (en) * 2006-12-05 2008-04-28 주식회사 피코스텍 Cosmetic composition containing oriental herb extract and nano ceramide
KR100947282B1 (en) * 2009-10-23 2010-03-16 신근우 Composition of environmental antiseptic
KR101224168B1 (en) * 2011-03-09 2013-01-21 헤내스 주식회사 Cosmetic composition containing Papain
KR101226089B1 (en) * 2010-03-24 2013-01-24 주식회사 에스알테크 Compositions for Preventing, Ameliorating, or Treating Symptom of Atopic Dermatitis
KR101248503B1 (en) * 2010-05-31 2013-04-03 경상대학교산학협력단 Composition for improving atopic dermatitis comprising hot water extract of green tea and ethanol extract of green tea
KR20200101658A (en) 2019-02-20 2020-08-28 강모제 Cosmetic composition containing Zanthoxylum piperitum De Candolle
KR20210070074A (en) 2019-12-04 2021-06-14 천년산초의령 영농조합법인 Manufacturing method of cosmetic cream containing Zanthoxylum piperitum De Candolle
KR20220011331A (en) 2020-07-21 2022-01-28 송미희 Cosmetic composition for improving atopic dermatitis and method of manufacturing the same
KR20230159672A (en) 2022-05-14 2023-11-21 정유진 Atopy, acne, skin irritation improved functional cosmetics containing hydrogen and natural derived preservation substance and their manufacturing method

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1036283A (en) * 1996-07-18 1998-02-10 Ichimaru Pharcos Co Ltd Fibroblast proliferation promoting agent
JPH11302155A (en) * 1998-04-24 1999-11-02 La Shinshia Kk Skin external preparation for atopic dermatitis
JP2000169383A (en) * 1998-12-07 2000-06-20 Ichimaru Pharcos Co Ltd Antiallergic agent
KR20000046633A (en) * 1998-12-31 2000-07-25 성재갑 Composition for treatment of atopic dermatonosis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1036283A (en) * 1996-07-18 1998-02-10 Ichimaru Pharcos Co Ltd Fibroblast proliferation promoting agent
JPH11302155A (en) * 1998-04-24 1999-11-02 La Shinshia Kk Skin external preparation for atopic dermatitis
JP2000169383A (en) * 1998-12-07 2000-06-20 Ichimaru Pharcos Co Ltd Antiallergic agent
KR20000046633A (en) * 1998-12-31 2000-07-25 성재갑 Composition for treatment of atopic dermatonosis

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100451444B1 (en) * 2001-10-19 2004-10-06 이석일 Cosmetic composition for treating atopic dermattis
KR20040026268A (en) * 2002-09-23 2004-03-31 바이오스펙트럼 주식회사 Topical composition for lowering pruritus or damaged skin barrier caused by atopic dermatitis
KR100564153B1 (en) * 2002-11-28 2006-03-27 주식회사 에이치 엔 비티 A composition for improving the atopic dermatitis
KR100700912B1 (en) * 2005-12-30 2007-03-28 고려대학교 산학협력단 Human Cell Binding Inhibitory Activity of Acne Bacillus and Atopic Staphylococcus aureus Containing Acidic Polysaccharides Isolated from Green Tea Leaves
KR100723370B1 (en) * 2005-12-30 2007-05-30 대구한의대학교산학협력단 Cosmetic composition comprising the extract of scutellaria baicalensis and coptis chinensis showing hydrating effect and antibacterial effect
KR100797139B1 (en) * 2006-04-11 2008-01-24 허재원 Pack composition comprising Skullcap and Black Rice
KR100824958B1 (en) * 2006-12-05 2008-04-28 주식회사 피코스텍 Cosmetic composition containing oriental herb extract and nano ceramide
KR100947282B1 (en) * 2009-10-23 2010-03-16 신근우 Composition of environmental antiseptic
KR101226089B1 (en) * 2010-03-24 2013-01-24 주식회사 에스알테크 Compositions for Preventing, Ameliorating, or Treating Symptom of Atopic Dermatitis
KR101248503B1 (en) * 2010-05-31 2013-04-03 경상대학교산학협력단 Composition for improving atopic dermatitis comprising hot water extract of green tea and ethanol extract of green tea
KR101224168B1 (en) * 2011-03-09 2013-01-21 헤내스 주식회사 Cosmetic composition containing Papain
KR20200101658A (en) 2019-02-20 2020-08-28 강모제 Cosmetic composition containing Zanthoxylum piperitum De Candolle
KR20210070074A (en) 2019-12-04 2021-06-14 천년산초의령 영농조합법인 Manufacturing method of cosmetic cream containing Zanthoxylum piperitum De Candolle
KR20220011331A (en) 2020-07-21 2022-01-28 송미희 Cosmetic composition for improving atopic dermatitis and method of manufacturing the same
KR20230159672A (en) 2022-05-14 2023-11-21 정유진 Atopy, acne, skin irritation improved functional cosmetics containing hydrogen and natural derived preservation substance and their manufacturing method

Similar Documents

Publication Publication Date Title
EP2278986B1 (en) A product for topical administration
KR100772575B1 (en) External composition for improvement of skin containing herbal extracts
KR101516002B1 (en) Cosmetic composite for alleviating atopic dermatitis and the manufacturing for the same
KR102501046B1 (en) Cosmetic composition for moisturizing and improvement of skin itching comprising the extract of natural products
KR20020076375A (en) Cosmetics Useful for atopic skin
KR101494661B1 (en) Composition for hair or scalp treatment comprising fermented black garlic residue and method of preparing the same
KR20080002279A (en) Lip cosmetic composition for atopy skin
KR100905386B1 (en) Composition of oriental cosmetics for atopy skin containing herbal extract
KR20130015339A (en) Cream composition for treating acne
CN111228207B (en) Dampness-rash-eliminating hip-protecting cream and preparation method thereof
KR101142541B1 (en) Anti-wrinkle cosmetic composition containing oriental herb extract treated by enzyme and its extraction method
KR101397160B1 (en) Cosmetic compositon for skin-irritation alleviation with Inula britannica var. chinensis, Cynanchi Radix and Lysimachia foenum-graecum Hance
KR101142977B1 (en) Cosmetic Composition Comprising Opuntia Five Element Tea Mixed Extract For Improving Atopic skin And Manufacturing Method Thereof And Cosmetic Material Containing The Same
KR100915711B1 (en) Moisturizing, anti-inflammatory, antibacterial or anti-allergic compositions, and preparation methods thereof
KR101047612B1 (en) Cosmetic composition for reducing or treating acne and acne rash
CN115429725B (en) Cosmetic composition for antioxidation, anti-inflammatory and skin tranquilization
KR20030055154A (en) A composition for treating a dermatitis and a method of preparing the same
KR20200082813A (en) Cosmetic and pharmaceutical compositin comprising sasa quelpaertensis extract and urea
KR102501047B1 (en) Cosmetic composition helping in improving water content in corneous lower layer comprising the extract of natural products
KR20090075950A (en) Therapeutical compositions for obstinate atopic dermatitis
KR101866518B1 (en) A cosmetic composition for manufacturing by the using of propolis improving onychomycosis
JP4295841B2 (en) Antiallergic topical agent
KR20090042073A (en) Compositions of the specific herb extracted complex which has the function of alleviating the irritation and those of cosmetics for allergic skin containing it
KR100900197B1 (en) Compositions of ointments controlling skin immune system containing specific herbal extract complex
KR20200064204A (en) Composition for improving atopic dermatitis containing Dendropanax morbifera Lev. extract

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application